UY25244A1 -
USE OF A SPECIFIC ANTAGONIST OF 5 HT2 RECEPTORS FOR THE PREPARATION OF DRUGS USEFUL IN THE TREATMENT OF SLEEP APNEA SYNDROME
- Google Patents
USE OF A SPECIFIC ANTAGONIST OF 5 HT2 RECEPTORS FOR THE PREPARATION OF DRUGS USEFUL IN THE TREATMENT OF SLEEP APNEA SYNDROME
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SynthelabofiledCriticalSanofi Synthelabo
Priority to UY25244ApriorityCriticalpatent/UY25244A1/en
Priority to UY25339Aprioritypatent/UY25339A1/en
Publication of UY25244A1publicationCriticalpatent/UY25244A1/en
Uso de 1-(2-fluorofenil)-3-(4-hidrixifenil)-prop-2-en-1-ona-o-(2-dimetilaminoetil)-ixima o de una de sus sales aceptables desde el punto de vista farmacéutico caracterizado porque es para la preparación de medicamentos útiles en el tratamiento del síndrome de la apnea del sueno.Use of 1- (2-fluorophenyl) -3- (4-hydroxyphenyl) -prop-2-en-1-one-o- (2-dimethylaminoethyl) -ixime or one of its pharmaceutically acceptable salts characterized in that it is for the preparation of useful drugs in the treatment of sleep apnea syndrome.
UY25244A1998-11-111998-11-11
USE OF A SPECIFIC ANTAGONIST OF 5 HT2 RECEPTORS FOR THE PREPARATION OF DRUGS USEFUL IN THE TREATMENT OF SLEEP APNEA SYNDROME
UY25244A1
(en)
PHARMACEUTICAL COMPOSITION CONTAINING 3-2 (DIMETHYLAMINE) ETHYL-N-METHYL-1H-INDOL-5-METHANE SULPHONAMIDE, RELATIVE PROCEDURE FOR PREPARATION AND USE OF THE SAME IN TREATMENT OF MAMMALS
Use of at least one compound selected from melatonin, melatoninergic agents, melatonin agonists and antagonists, in an amount of 0.0025-50 mg, to prepare a useful medicine for the treatment and improvement of the restorative quality of sleep.